Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Ambit Biosciences (NASDAQ:AMBI.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AMBI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.02)
Submitted August 17, 2013

Ambit seemed to be enjoying the biopharma summer of love along with all the other recent IPO's until the upward momentum hit a brick wall on August 6. There was no bad news, the earnings PR wouldn't come out for another week, lockup expiration isn't… More

cydro (< 20)
Submitted September 06, 2013

Ambit's only drug useful to investors is used to treat an awful cancer, and so it's one of those investments that would help you sleep at night. However, the seemingly successful trials don't hold up to scrutiny very well. Seeking Alpha contributor… More

NASDAQ:AMBI.DL VS S&P 500 (SPY)

NASDAQ:AMBI.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about AMBI.DL.

No one has written a Pitch for AMBI.DL stock yet. Tell us why you think AMBI.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in AMBI.DL.

No players have picked AMBI.DL yet. Tell us why you think AMBI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AMBI.DL.